Please login to the form below

Not currently logged in

Pemphis vulgaris

This page shows the latest Pemphis vulgaris news and features for those working in and with pharma, biotech and healthcare.

GSK unit takes new ofatumumab formulation into phase III

GSK unit takes new ofatumumab formulation into phase III

The trial in patients with pemphigus vulgaris, a serious condition in which patients develop painful blisters in the mouth and on the skin that can become infected. ... At the moment the standard treatment for pemphigus vulgaris - which affects around

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...